CMyBP-C and MLC2 As Diagnostic Markers of Cardiac Injury
The invention relates to markers for acute myocardial infarction (AMI), particularly markers that may be used in the rapid and accurate diagnosis of AMI or reinfarction. A method of diagnosing cardiac injury comprising identifying an elevated concentration of cardiac myosin binding protein C (cMyBP-C) or a fragment thereof or myosin regulatory light chain 2 (MLC2) or a fragment thereof in a sample obtained from a subject.
WO 2,010,130,985 [MORE INFO
MAYR MANUEL [GB]; JACQUET SEBASTIEN [FR]; MARBER MICHAEL [GB]; GAUTEL MATHIAS [GB]
Type of Offer:
« More Medical Devices Patents« More Diagnostic Patents